Related Experiment Video

Updated: May 26, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

KMUP-1 inhibits H441 lung epithelial cell growth, migration and proinflammation via increased NO/CGMP and inhibited

B N Wu1, H Y Chen, C P Liu

  • 1Department of Pharmacology, Kaohsiung Medical University, Kaohsiung, Taiwan.

International Journal of Immunopathology and Pharmacology
|January 11, 2012
PubMed

Insights

KMUP-1 demonstrates anti-inflammatory effects by protecting soluble guanylate cyclase (sGC) and inhibiting vascular endothelial growth factor (VEGF) in lung epithelial cells, suggesting therapeutic potential for epithelial inflammation.

Area of Science:

  • Cell Biology
  • Pharmacology
  • Pulmonary Medicine

Background:

  • Epithelial proinflammation in the lungs is a significant therapeutic target.
  • Hypoxia plays a crucial role in lung epithelial cell responses, including inflammation and angiogenesis.
  • Soluble guanylate cyclase (sGC) and vascular endothelial growth factor (VEGF) are implicated in hypoxia-induced lung pathologies.

Purpose of the Study:

  • To investigate the protective effects of KMUP-1 on sGC and its inhibition of VEGF expression in lung epithelial cells under hypoxic conditions.
  • To explore the anti-proinflammatory mechanisms of KMUP-1 in H441 lung epithelial cells.
  • To assess the therapeutic potential of KMUP-1 in targeting epithelial inflammation.

Main Methods:

  • H441 lung epithelial cells were cultured under hypoxic conditions (24-72 h).
  • The effects of KMUP-1 on cell cycle, survival, migration, protein expression (eNOS, sGC, PKG, ROCK-II, HIF-1alpha, VEGF, iNOS, PDE-5A), and apoptosis markers were analyzed.
  • Specific inhibitors (L-NAME, Rp-8-CPT-cGMPS) and agonists (U46619, TNF-alpha) were used to elucidate signaling pathways.

Main Results:

  • KMUP-1 (1-100 microM) induced G0/G1 cell cycle arrest, reduced cell survival and migration, and increased p21/p27.
  • KMUP-1 restored eNOS, increased sGC and PKG, and inhibited Rho kinase II (ROCK-II).
  • KMUP-1 suppressed hypoxia-induced factor-1alpha (HIF-1alpha) and VEGF, and inhibited TNF-alpha-induced iNOS and U46619-induced PDE-5A and phospho-p38 MAPK, demonstrating broad anti-inflammatory actions.

Conclusions:

  • KMUP-1 exhibits significant anti-proinflammatory and anti-neoplastic properties by inhibiting ROCK-II/VEGF in hypoxia.
  • KMUP-1 effectively reduces epithelial inflammation through multiple anti-inflammatory pathways.
  • KMUP-1 shows therapeutic promise for treating inflammatory lung conditions.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...